BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery

NCT01225822 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1973

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: Enoxaparin
DRUG: BIBR 1048
DRUG: BIBR 1048
DRUG: BIBR 1048
DRUG: BIBR 1048

Sponsor

Boehringer Ingelheim